100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 · Chutes & Ladders—BIO lands rare disease advocate John Crowley as CEO. The redesign is tooled to give leaders more resources, Crowley said, though the restructure led to the departure of 30...
BIO CEO John Crowley interview: China, vaccines, and Trump - STAT
Jul 18, 2024 · W ASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues.
John Crowley (businessman) - Wikipedia
John Francis Crowley (born April 7, 1967) is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. [1] He served as the chairman and CEO of Amicus Therapeutics.
He Designed Drugs to Save His Children. Now He’s Working to …
Dec 5, 2023 · Nearly a quarter-century after plunging into biotech to find drugs to save Megan and her younger brother, Patrick, from a rare and deadly genetic disease, Crowley feared the battle had suddenly...
BIO selects John Crowley as new CEO - STAT
Dec 5, 2023 · W ASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday....
Meet John Crowley: Biotech Visionary, Devoted Father, and New …
Jun 17, 2024 · As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a unique blend of personal passion and professional expertise to his role.
John F. Crowley at GEN State of Biotechnology 2024 - Bio.News
Sep 13, 2024 · John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), gave a keynote about BIO’s work, how the current political landscape is affecting the industry, the Inflation Reduction Act (IRA), the BIOSECURE Act, and much more.
Admiral William H. McRaven speaks at BIO 2024 - Bio.News
Jun 5, 2024 · Admiral William H. McRaven sat down with BIO President & CEO John F. Crowley at the 2024 BIO Convention to discuss leadership and hope.
John F. Crowley at 2024 Global Genes RARE Advocacy Summit - Bio.News
Sep 30, 2024 · Driving a ‘patient-led revolution’: John F. Crowley at the Global Genes RARE Advocacy Summit. Going from “we have a problem” to “we have an idea” to “we have a solution” is an important journey for patient advocates and their family members in the rare disease community, said John Crowley, President & CEO of the Biotechnology ...
Amicus CEO John Crowley Outlines Progress in Fabry ... - Fabry Disease News
Aug 21, 2019 · Read our exclusive interview with John Crowley, CEO of Amicus Therapeutics, on the latest therapies for Pompe, Fabry, Batten, and other rare diseases.